Old Web
English
Sign In
Acemap
>
authorDetail
>
Stephen Hitchcock
Stephen Hitchcock
Takeda Pharmaceutical Company
Chemistry
Pharmacology
Enzyme
Cell
Cathepsin D
3
Papers
17
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
First-Time Disclosure of CVN424, a Potent and Selective GPR6 Inverse Agonist for the Treatment of Parkinson's Disease: Discovery, Pharmacological Validation, and Identification of a Clinical Candidate.
2021
Journal of Medicinal Chemistry
Huikai Sun
Holger Monenschein
Hans H Schiffer
Holly Reichard
Kikuchi Shota
Hopkins Maria
Todd Macklin
Stephen Hitchcock
Mark L. Adams
Jason Green
Jason W. Brown
Murphy Sean
Nidhi Kaushal
Deanna Collia
Steve Moore
William J. Ray
Mark B. L. Carlton
Nicola Brice
Show All
Source
Cite
Save
Citations (0)
Hydroxyethylamine-based inhibitors of BACE1: P1-P3 macrocyclization can improve potency, selectivity, and cell activity.
2013
Bioorganic & Medicinal Chemistry Letters
Lewis D. Pennington
Douglas A. Whittington
Michael D. Bartberger
Steven R. Jordan
Holger Monenschein
Thomas Nguyen
Bryant Yang
Qiufen M. Xue
Filisaty Vounatsos
Robert C. Wahl
Kui Chen
Stephen Wood
Martin Citron
Vinod F. Patel
Stephen Hitchcock
Wenge Zhong
Show All
Source
Cite
Save
Citations (15)
1